![Drug resistant E. coli could be rapidly detected using newly developed technique. [NIH]](https://www.genengnews.com/wp-content/uploads/2018/08/24661308922_3eb66388f6_o8020087571-218x150.jpg "Dangerous E. coli Strain Reveals Potential New Drug Target")
At the SynBioBeta 2019 conference in San Francisco, Inscripta launched the Onyx—a fully automated benchtop instrument for genome-scale engineering. The CRISPR-mediated, massively parallel platform—which includes software, consumables, instrument, and assays enables researchers to engineer microbial libraries containing the full breadth and scope of possible edit types, in their own labs . . .
